The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease
暂无分享,去创建一个
Jorge R. Oksenberg | Sergio E. Baranzini | Lawrence Steinman | Raymond A. Sobel | R. Heller | R. Pedotti | D. Mitchell | R. Sobel | L. Steinman | S. Baranzini | J. Oksenberg | D. Denhardt | C. Bernard | S. Rittling | M. Karpuj | Dorothée Chabas | Dennis Mitchell | Claude C. A. Bernard | Susan R. Rittling | David T. Denhardt | Christopher Lock | Marcela Karpuj | Rosetta Pedotti | Renu Heller | D. Chabas | C. Lock
[1] D. Heinegård,et al. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[2] K. Mohler,et al. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. , 1992, Journal of immunology.
[3] D. Denhardt,et al. Osteopontin: a protein with diverse functions , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] J. Gimble,et al. Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells , 1993, Journal of cellular physiology.
[5] L. Steinman,et al. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. , 1994, The Journal of clinical investigation.
[6] D. Laskin,et al. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. , 1994, The Journal of biological chemistry.
[7] C. Polman,et al. The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis , 1995, Nature.
[8] M. Chen,et al. Vitronectin and Integrin Vitronectin Receptor Localization in Multiple Sclerosis Lesions , 1995, Journal of neuropathology and experimental neurology.
[9] J. Haines,et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex , 1996, Nature Genetics.
[10] P. Goodfellow,et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 , 1996, Nature Genetics.
[11] D. Hinds,et al. A full genome search in multiple sclerosis , 1996, Nature Genetics.
[12] L Steinman,et al. Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System , 1996, Cell.
[13] K. Becker,et al. Analysis of a sequenced cDNA library from multiple sclerosis lesions , 1997, Journal of Neuroimmunology.
[14] N. Baumann,et al. Expression of TNFα in central neurons of Lewis rat spinal cord after EAE induction , 1997 .
[15] D. Mitchell,et al. Short peptide-based tolerogens without self-antigenic or pathogenic activity reverse autoimmune disease. , 1998, Journal of immunology.
[16] Piero Carninci,et al. Characterization of gene expression in mouse blastocyst using single-pass sequencing of 3995 clones. , 1998, Genomics.
[17] C. Bernard,et al. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. , 1998, Autoimmunity.
[18] M. McKee,et al. Mice Lacking Osteopontin Show Normal Development and Bone Structure but Display Altered Osteoclast Formation In Vitro , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] S. Rittling,et al. Detection of mouse osteopontin by western blotting. , 1998, Biochemical and biophysical research communications.
[20] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[21] H. Garren,et al. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation. , 1999, Journal of immunology.
[22] D. Denhardt,et al. Osteopontin Function in Pathology: Lessons from Osteopontin-Deficient Mice , 1999, Nephron Experimental Nephrology.
[23] I. Weissman,et al. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Cha,et al. Expression of osteopontin mRNA in the adult rat brain , 1999, Neuroscience Letters.
[25] M. Glimcher,et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. , 2000, Science.
[26] D. Pitt,et al. Glutamate excitotoxicity in a model of multiple sclerosis , 2000, Nature Medicine.
[27] R. Pedotti,et al. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide , 2001, Nature Immunology.
[28] Lawrence Steinman,et al. Multiple sclerosis: a two-stage disease , 2001, Nature Immunology.
[29] D. Torchia,et al. Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. , 2001, Biochemical and biophysical research communications.